Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Fihn SD et al. JAMA Network Open.
Published: April 24, 2020. doi:10.1001/jamanetworkopen.2020.9035
Correction: This article was corrected on April 27, 2020, to fix an incorrect drug name in the third paragraph.
Corresponding Author: Stephan D. Fihn, MD, MPH, Department of Medicine, Harborview Medical Center, University of Washington, 325 Ninth Ave, PO Box 359780, Seattle, WA 98104 (email@example.com).
Conflict of Interest Disclosures: None reported.
Disclaimer: The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the US government.
MGS , Val
FFA , Sampaio
et al; CloroCovid-19 Team. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial. JAMA Netw Open
. 2020;3(4):e208857. doi:10.1001/jamanetworkopen.2020.8857Google Scholar